Revelation Financial Statements From 2010 to 2024

REVBW Stock  USD 0.01  0.0001  0.81%   
Revelation Biosciences financial statements provide useful quarterly and yearly information to potential Revelation Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Revelation Biosciences financial statements helps investors assess Revelation Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Revelation Biosciences' valuation are summarized below:
Earnings Share
(4.77)
There are over eighty-seven available trending fundamental ratios for Revelation Biosciences, which can be analyzed over time and compared to other ratios. All traders should should check out Revelation Biosciences' recent fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Market Cap is likely to drop to about 3.9 M in 2024. Enterprise Value is likely to climb to about (1.8 M) in 2024
Check Revelation Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revelation Biosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 7 M, Total Operating Expenses of 7 M or Total Other Income Expense Net of 9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.54. Revelation financial statements analysis is a perfect complement when working with Revelation Biosciences Valuation or Volatility modules.
  
Check out the analysis of Revelation Biosciences Correlation against competitors.
For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.

Revelation Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets12.8 M12.2 M2.5 M
Slightly volatile
Other Current Liabilities2.2 M4.2 M829.1 K
Slightly volatile
Total Current Liabilities2.9 M5.6 M1.1 M
Slightly volatile
Non Current Assets Total61.8 K65.1 K4.9 M
Pretty Stable
Common Stock Shares Outstanding240.1 K228.6 K39.4 K
Slightly volatile
Liabilities And Stockholders Equity12.8 M12.2 M2.5 M
Slightly volatile
Total Liabilities2.9 M5.6 M1.1 M
Slightly volatile
Accounts Payable928.5 K1.4 M864.2 K
Very volatile
Cash6.3 M12 MM
Slightly volatile
Cash And Short Term Investments6.3 M12 MM
Slightly volatile
Short Term Investments420.2 K472.8 K514.8 K
Slightly volatile
Other Current Assets198.9 K155.8 K164.9 K
Slightly volatile
Other Stockholder Equity21.6 M32.1 M10.4 M
Slightly volatile
Total Current Assets6.6 M12.1 M5.1 M
Slightly volatile
Capital Stock252265796.8 K
Pretty Stable
Common Stock2522651.9 K
Slightly volatile
Short and Long Term Debt Total13.4 K15.1 K16.4 K
Slightly volatile
Short Term Debt3.5 M3.3 M665 K
Slightly volatile
Current Deferred Revenue2.3 M2.6 M2.9 M
Slightly volatile

Revelation Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating ExpensesM8.7 M2.6 M
Slightly volatile
Total Operating ExpensesM8.7 M2.6 M
Slightly volatile
Depreciation And Amortization38 K25 K14.3 K
Slightly volatile
Selling General Administrative4.2 M4.5 M1.4 M
Slightly volatile
Selling And Marketing Expenses21.4 K22.5 K112.1 K
Slightly volatile
Research Development4.5 M4.1 M1.4 M
Slightly volatile
Interest Expense30.7 K31.5 K39.9 K
Slightly volatile
Cost Of Revenue35.8 K25 K62.1 K
Slightly volatile
Reconciled Depreciation24.5 K25 K18.4 K
Slightly volatile

Revelation Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow14.8 M12 M51.7 M
Slightly volatile
Stock Based Compensation267.2 K155.7 K111.8 K
Slightly volatile
Begin Period Cash FlowM5.3 M55.5 M
Slightly volatile
Total Cash From Financing Activities22.3 M14 M58.4 M
Slightly volatile
Depreciation24.5 K25 K18.4 K
Slightly volatile
Issuance Of Capital Stock12.4 M14 M8.9 M
Slightly volatile
Dividends Paid6.1 M6.9 M7.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables556 K861.3 K539.6 K
Slightly volatile
Capex To Depreciation2.0E-42.0E-46.2907
Slightly volatile
Payables Turnover0.01750.01840.1
Slightly volatile
Cash Per Share49.9752.5952460
Slightly volatile
Days Payables Outstanding20.8 K19.8 K5.6 K
Slightly volatile
Income Quality63.6260.59088.5082
Slightly volatile
Net Debt To EBITDA13212639.8962
Slightly volatile
Current Ratio2.232.18293.2379
Slightly volatile
Graham Number17.6718.6013186
Slightly volatile
Capex Per Share0.00.011.2293
Slightly volatile
Days Of Payables Outstanding20.8 K19.8 K5.6 K
Slightly volatile
Ebt Per Ebit0.01320.01391.5486
Very volatile
Effective Tax Rate0.00350.003731.4956
Slightly volatile
Quick Ratio2.232.18293.2379
Slightly volatile
Net Income Per E B T0.80.90.9772
Slightly volatile
Cash Ratio2.12.15493.1274
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.810.910.9916
Slightly volatile

Revelation Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.9 M4.1 M72.8 M
Slightly volatile

Revelation Fundamental Market Drivers

Cash And Short Term Investments12 M

About Revelation Biosciences Financial Statements

Revelation Biosciences investors use historical fundamental indicators, such as Revelation Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revelation Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.6 M2.3 M
Cost Of Revenue25 K35.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revelation Stock Analysis

When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.